Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+9.13%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$100B
AUM Growth
-$15.7B
Cap. Flow
-$22.5B
Cap. Flow %
-22.43%
Top 10 Hldgs %
15.09%
Holding
3,879
New
490
Increased
1,156
Reduced
1,673
Closed
545

Sector Composition

1 Healthcare 22.93%
2 Technology 16.66%
3 Consumer Staples 12.21%
4 Consumer Discretionary 9.52%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
JAGX icon
3676
Jaguar Health
JAGX
$3.85M
0
-$53K
JBLU icon
3677
JetBlue
JBLU
$1.85B
-300,000
Closed -$3.27M
JFIN
3678
Jiayin Group
JFIN
$619M
-17,758
Closed -$69K
JPM icon
3679
JPMorgan Chase
JPM
$809B
-2,204,786
Closed -$207M
KAI icon
3680
Kadant
KAI
$3.85B
-26,100
Closed -$2.6M
KALA icon
3681
KALA BIO
KALA
$102M
-344
Closed -$181K
KALV icon
3682
KalVista Pharmaceuticals
KALV
$796M
-41,346
Closed -$500K
KB icon
3683
KB Financial Group
KB
$28.5B
-24,800
Closed -$690K
KBE icon
3684
SPDR S&P Bank ETF
KBE
$1.62B
-22,500
Closed -$710K
KBH icon
3685
KB Home
KBH
$4.63B
-747,790
Closed -$22.9M
KNTK icon
3686
Kinetik
KNTK
$2.58B
-33,200
Closed -$210K
KODK icon
3687
Kodak
KODK
$477M
-111,331
Closed -$248K
KPRX icon
3688
Kiora Pharmaceuticals
KPRX
$9.2M
-154
Closed -$267K
KPTI icon
3689
Karyopharm Therapeutics
KPTI
$57.2M
-12,120
Closed -$3.44M
KRE icon
3690
SPDR S&P Regional Banking ETF
KRE
$3.99B
-18,000
Closed -$691K
KRKR
3691
36Kr Holdings
KRKR
$10.3M
-964
Closed -$64K
KSS icon
3692
Kohl's
KSS
$1.86B
-365,576
Closed -$7.59M
LE icon
3693
Lands' End
LE
$439M
-18,083
Closed -$145K
LEA icon
3694
Lear
LEA
$5.91B
-2,900
Closed -$316K
LEG icon
3695
Leggett & Platt
LEG
$1.35B
-562,500
Closed -$19.8M
LEN icon
3696
Lennar Class A
LEN
$36.7B
-473,355
Closed -$28.2M
LGND icon
3697
Ligand Pharmaceuticals
LGND
$3.25B
-217,277
Closed -$15.2M
LMAT icon
3698
LeMaitre Vascular
LMAT
$2.21B
-29,800
Closed -$787K
LMFA icon
3699
LM Funding America
LMFA
$16.6M
-736
Closed -$30K
LPCN icon
3700
Lipocine
LPCN
$15.7M
-18,594
Closed -$398K